EPA approval requested in California for Oxitec GM disease-reducing mosquito release, following successful implementation in Florida

Credit: Getty Images
Credit: Getty Images

Climate change has allowed disease-transmitting mosquitoes to advance into new regions throughout the Western U.S., posing a threat to tens of millions of people. The invasive Aedes aegypti, vector of dengue, Zika, heartworm and other diseases, is now present in more than 300 cities and towns across California, and its range continues to expand. There are no treatments or vaccines for many of the diseases transmitted by Aedes aegypti and innovative mosquito control techniques are urgently needed.

After a comprehensive federal review, Oxitec’s safe, non-biting Friendly™ Aedes aegypti control technology was approved by the EPA for a pilot program in the Florida Keys, which has been underway since April 2021.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

After receiving interest from a range of mosquito control districts in northern, central and southern California, Oxitec has applied to the EPA for authorization to expand the areas within which it can pilot its Friendly™ Aedes aegypti technology in collaboration with government partners. Upon EPA and state regulatory approvals, Oxitec would work closely with interested mosquito control agencies to determine the location, size, and scope of a pilot program or programs.  Any proposal would be preceded by extensive community education and outreach efforts.

Read the original post

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-2-2026-02_03_32-PM
How much of a problem is AI’s water use?
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.